Co-Diagnostics Inc (CODX)

$7.01 0. (0.00%)

16:00 EDT CODX Stock Quote Delayed 30 Minutes

CODX Stock Pops as Co-Diagnostics Ships Out Monkeypox Tests

By Josh Enomoto, InvestorPlace Contributor Jul 11, 2022

CODX stock is up during early afternoon trading as Co-Diagnostics ships out monkeypox testing reagents to help deal with the outbreak.

7 Stocks to Buy to Hedge Against Omicron Variant Risks

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Volume:

Previous Close -

Market Cap 238.25M

PE Ratio 5.39

EPS 1.3

Volume (Avg. Vol.) 797

Day's Range -

52-Week Range $3.66 - $11.82

Dividend & Yield N/A (N/A)

CODX Stock Predictions, Articles, and Co-Diagnostics Inc News

From InvestorPlace
From the Web

If You Rode the Co-Diagnostics Stock Pandemic Highs, It’s Time to Bail

By Alex Sirois Apr 7, 2021

CODX stock rose on the pandemic, but its prospects moving forward look bleak with a sales strategy that is suspect at best.

Co-Diagnostics Stock Is an Out-and-Out Buy Before the Earnings Release

By David Moadel, InvestorPlace Contributor Mar 25, 2021

CODX stock's true value isn't fully appreciated by the investing community, and this could provide a setup for an explosive move.

The Top Reasons to Consider Co-Diagnostics Stock

By Ian Cooper Jul 30, 2020

With a desperate need for more test test kits for the novel coronavirus, shares of CODX stock could continue to trend higher.

Co-Diagnostics Stock: Trading the Russell 2000 Index Catalyst

By Ian Bezek, InvestorPlace Contributor Jun 22, 2020

Co-Diagnostics will be on the move over the next week. Don't confuse a technical trade for a strong long-term investment case in CODX stock.

Co-Diagnostics Gets Sued, Investors Shrug

By Tyler Craig, Tales of a Technician Jun 17, 2020

Monday's lawsuit hasn't impacted the chart of Co-Diagnostics one bit. Here are the price levels in CODX stock that I'd trade around right now.

Co-Diagnostics Stock Is a Fun Day Trade but It Is No Investment

By Faizan Farooque Jun 17, 2020

CODX stock will start to tumble back to earth as more competitors enter the testing space, and the impact of Covid-19 subsides.

7 Risky Stocks That Are Worth a Gamble

By Louis Navellier and the InvestorPlace Research Staff Jun 8, 2020

These seven A- and B-rated names are some of the top risky stocks to buy for enterprising investors. Here's what you should know about each company.

Don’t Cancel Your Visit With Co-Diagnostics Stock Just Yet

By Josh Enomoto, InvestorPlace Contributor Jun 8, 2020

CODX stock took a hit as economic indicators suggested a sooner-than-expected recovery. But don’t completely ignore shares just yet.

Co-Diagnostics Stock Will Meet High Analyst Expectations

By Louis Navellier and the InvestorPlace Research Staff Jun 5, 2020

The price target for CODX stock has been raised, but the testing-kit leader should easily clear the bar. More upside ahead.

It May Be Time to Take Profits in Co-Diagnostics Stock

By Tezcan Gecgil, InvestorPlace Contributor Jun 5, 2020

The rush to develop a COVID-19 diagnostic test has pushed CODX stock to new highs. But investors may need more scientific evidence to stay in the shares long-term.

Co-Diagnostics Could Be a Prudent Coronavirus Play

By Todd Shriber, InvestorPlace Contributor Jun 4, 2020

CODX stock could continue delivering upside if its novel coronavirus test kit proves accurate and vaccines take awhile to come to market.

Make This Biotech Play if You Like Co-Diagnostics’ Chances

By Will Ashworth, InvestorPlace Contributor Jun 3, 2020

From an investment standpoint, I’m always thinking about my options. I don’t necessarily have to invest in CODX stock because there are other potential options available, ones probably safer in the grand scheme of things.